Loading clinical trials...
Loading clinical trials...
A Randomised, Double-Blind, Parallel Group, Multicentre Study to Assess the Efficacy and Safety of Four Concentrations of Depigoid® Phleum in Patients With Allergic Rhinitis and/or Rhinoconjunctivitis With or Without Intermittent Asthma
Conditions
Interventions
Depigoid Phleum
Locations
2
Germany
Hippke, Ear-Nose-Throat specialist
Berlin, Germany
Zentrum für Rhinologie und Allergie
Wiesbaden, Germany
Start Date
October 1, 2012
Primary Completion Date
April 1, 2013
Completion Date
June 1, 2013
Last Updated
November 19, 2013
Lead Sponsor
Leti Pharma GmbH
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions